Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1078983 (AZD-2014) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
protein kinase, DNA-activated, catalytic subunit/DNA-dependent protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3142] [GtoPdb: 2800] [UniProtKB: P78527] | ||||||||
ChEMBL | Inhibition of DNA-PK | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
Kv11.1/HERG in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL240] [GtoPdb: 572] [UniProtKB: Q12809] | ||||||||
ChEMBL | Inhibition of human ERG | B | 5.08 | pIC50 | 8300 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1212-1216 [PMID:23375793] |
mechanistic target of rapamycin kinase/mTORC1 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL4296661] [GtoPdb: 2109] [UniProtKB: P42345, Q8N122, Q9BVC4] | ||||||||
ChEMBL | Inhibition of mTORC1 in human MDA-MB-468 cells assessed as reduction of pS6 phosphorylation at Ser235/236 after 2 hrs | B | 6.18 | pIC50 | 660 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1212-1216 [PMID:23375793] |
GtoPdb | Inhibition of immunoprecipitated mTORC1 (S6K1 as substrate) and mTORC2 (Akt as substrate). | - | 8 | pIC50 | 10 | nM | IC50 | Biochem J (2009) 421: 29-42 [PMID:19402821] |
ChEMBL | Inhibition of mTORC1 in HEK293 cells using GST-tagged S6K1 or Akt1 as substrate after 30 mins by immunoblotting assay | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2018) 61: 4656-4687 [PMID:29211480] |
ChEMBL | Inhibition of mTORC1 in human HEK293 cells assessed as decrease in phosphorylated S6K level incubated for 30 mins by immunoblot assay | B | 8 | pIC50 | 10 | nM | IC50 | Eur J Med Chem (2020) 208: 112820-112820 [PMID:32966896] |
mechanistic target of rapamycin kinase/mTORC2 in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL4523999] [GtoPdb: 2109] [UniProtKB: P42345, Q6R327, Q9BPZ7, Q9BVC4] | ||||||||
GtoPdb | Inhibition of immunoprecipitated mTORC1 (S6K1 as substrate) and mTORC2 (Akt as substrate). | - | 8 | pIC50 | 10 | nM | IC50 | Biochem J (2009) 421: 29-42 [PMID:19402821] |
ChEMBL | Inhibition of mTORC2 in HEK293 cells using GST-tagged S6K1 or Akt1 as substrate after 30 mins by immunoblotting assay | B | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2018) 61: 4656-4687 [PMID:29211480] |
ChEMBL | Inhibition of mTORC2 in human HEK293 cells assessed as decrease in phosphorylated Akt level incubated for 30 mins by immunoblot assay | B | 8 | pIC50 | 10 | nM | IC50 | Eur J Med Chem (2020) 208: 112820-112820 [PMID:32966896] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4005] [GtoPdb: 2153] [UniProtKB: P42336] | ||||||||
ChEMBL | Inhibition PI3K-alpha-mediated PIP2 phosphorylation after 20 mins by alphascreen competition assay | B | 5.05 | pIC50 | 8900 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
ChEMBL | Inhibition of PI3Kalpha (unknown origin) using lipid PIP2 as substrate | B | 5.05 | pIC50 | 8900 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1212-1216 [PMID:23375793] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta/PI3-kinase p110-beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3145] [GtoPdb: 2154] [UniProtKB: P42338] | ||||||||
ChEMBL | Inhibition PI3K-beta-mediated PIP2 phosphorylation after 20 mins by alphascreen competition assay | B | 4.52 | pIC50 | >30000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
ChEMBL | Inhibition of PI3Kbeta (unknown origin) using lipid PIP2 as substrate | B | 4.52 | pIC50 | >30000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1212-1216 [PMID:23375793] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/PI3-kinase p110-delta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3130] [GtoPdb: 2155] [UniProtKB: O00329] | ||||||||
ChEMBL | Inhibition PI3K-delta-mediated PIP2 phosphorylation after 20 mins by alphascreen competition assay | B | 5.28 | pIC50 | >5300 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
ChEMBL | Inhibition of PI3Kdelta (unknown origin) using lipid PIP2 as substrate | B | 5.28 | pIC50 | 5300 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1212-1216 [PMID:23375793] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
ChEMBL | Inhibition PI3K-gamma-mediated PIP2 phosphorylation after 20 mins by alphascreen competition assay | B | 4.52 | pIC50 | >30000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
ChEMBL | Inhibition of PI3Kgamma (unknown origin) using lipid PIP2 as substrate | B | 4.52 | pIC50 | >30000 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1212-1216 [PMID:23375793] |
ATR serine/threonine kinase/Serine-protein kinase ATR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5024] [GtoPdb: 1935] [UniProtKB: Q13535] | ||||||||
ChEMBL | Inhibition of ATR | B | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
mechanistic target of rapamycin kinase/Serine/threonine-protein kinase mTOR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2842] [GtoPdb: 2109] [UniProtKB: P42345] | ||||||||
ChEMBL | Inhibition of mTORC2 in human U87MG cells assessed as phosphorylated AKT (Ser473) level after 2 hrs by Western blotting | B | 6.82 | pIC50 | 150 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
ChEMBL | Inhibition of mTORC1 in human U87MG cells assessed as phosphorylated S6 ribosomal protein (Ser235/236) level after 2 hrs by Western blotting | B | 7 | pIC50 | 100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
GtoPdb | Inhibition of immunoprecipitated mTORC1 (S6K1 as substrate) and mTORC2 (Akt as substrate). | - | 8 | pIC50 | 10 | nM | IC50 | Biochem J (2009) 421: 29-42 [PMID:19402821] |
ChEMBL | Inhibition of mTOR (unknown origin) | B | 8 | pIC50 | 10 | nM | IC50 | Bioorg Med Chem Lett (2021) 47: 128204-128204 [PMID:34139324] |
ChEMBL | Inhibition of recombinant FLAG-tagged mTOR expressed in HEK293 cells using biotinylated p70S6K substrate after 2 hrs by alphascreen competition assay | B | 8.52 | pIC50 | 3 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 5950-5953 [PMID:19762236] |
ChEMBL | Inhibition of recombinant FLAG-tagged mTOR (1362 to 2549) (unknown origin) expressed in HEK293 cells | B | 8.6 | pIC50 | 2.5 | nM | IC50 | Bioorg Med Chem Lett (2013) 23: 1212-1216 [PMID:23375793] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]